Area of research
Molecular Biology · Hematology
Research interest
Research interests include Protein Degradation and Inhibitors, Acute Myeloid Leukemia Research, RNA and protein synthesis mechanisms, and Multiple Myeloma Research and Treatments.
Menin-inhibition boosts CAR-T cell therapy against NPM1 mutated and KMT2A-rearranged acute myeloid leukemia
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with <i>MLL</i> rearrangement or <i>NPM1</i> mutation to venetoclax
Synergistic targeting of <i>FLT3</i> mutations in AML via combined menin-MLL and FLT3 inhibition